Clinical Trial

Efficacy and Safety of Doravirine in the Rapid Initiation

Name: Efficacy and Safety of Doravirine in the Rapid Initiation — clinical trial record (NCT07357584)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: RapiDO

Not Yet Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

Protocol title: "Efficacy and safety of doravirine in the rapid initiation of highly active antiretroviral therapy (HAART) in HIV-1positive patients without prior treatment."

Trial Details

NCT Number	NCT07357584
Lead Sponsor	Fundación Huésped Collaborators: MSD Pharmaceuticals LLC, Fundacion IDEAA
Conditions	HIV-1-infection
Enrollment	100 participants
Start Date	2026-07-13
Primary Completion	2028-01-13 (estimated)
Study Completion	2028-01-13 (estimated)
Updated on ClinicalTrials.gov	2026-01-22